Follow
Maria Kalyukina
Maria Kalyukina
PhD candidate, The University of Auckland
Verified email at aucklanduni.ac.nz
Title
Cited by
Cited by
Year
TAS‐120 cancer target binding: defining reactivity and revealing the first fibroblast growth factor receptor 1 (FGFR1) irreversible structure
M Kalyukina, Y Yosaatmadja, MJ Middleditch, AV Patterson, JB Smaill, ...
ChemMedChem 14 (4), 494-500, 2019
982019
Rotational freedom, steric hindrance, and protein dynamics explain BLU554 selectivity for the hinge cysteine of FGFR4
X Lin, Y Yosaatmadja, M Kalyukina, MJ Middleditch, Z Zhang, X Lu, ...
ACS Medicinal Chemistry Letters 10 (8), 1180-1186, 2019
202019
Structural characterisation of irreversible FGFR inhibition
M Kalyukina
PhD Thesis-University of Auckland, 2021
2021
SNAPSHOTS OF IRREVERSIBLE FGFR1 INHIBITION
M Kalyukina, Y Yosaatmadja, A Patterson, J Smaill, C Squire
PROTEIN SCIENCE 28, 17-18, 2019
2019
Developing Methods to Study Irreversible Inhibition of FGFR1
M Kalyukina
Masters Thesis-University of Auckland, 2016
2016
TAS-120
M Kalyukina, Y Yosaatmadja, MJ Middleditch, AV Patterson, JB Smaill, ...
The system can't perform the operation now. Try again later.
Articles 1–6